ARCHIVED: NOT AVAILABLE FOR CREDITIdentifying the Pregnant Patient: There's More to Know than 'Yes' or 'No'

Human chorionic gonadotropin (hCG) is used as a biomarker to determine a woman’s pregnancy status. The detection of hCG is commonly done by the use of qualitative hCG tests using urine or serum. While both sample types can be used, urine is often preferred due to its ability to be analyzed at the point-of-care. Urine hCG testing is plagued by several limitations yet these are often not appreciated by clinical care providers and laboratorians. This presentation will describe the limitations of qualitative urine and serum hCG tests and explain the causes of erroneous results. It will also describe the effect that qualitative hCG tests have on turnaround time and patient length of stay.

Originally presented on April 30, 2015 in Salt Lake City, Utah.

Lecture Presenter

David G. Grenache, PhD

Medical Director, Special Chemistry LaboratoryARUP LaboratoriesCo-Director, Electrophoresis and Manual Endocrinology LaboratoryARUP LaboratoriesProfessor of PathologyUniversity of Utah School of Medicine

Dr. Grenache is the medical director of the Special Chemistry Laboratory, a co-director of the Electrophoresis and Manual Endocrinology Laboratory, and the chief medical director of clinical chemistry at ARUP Laboratories. He is a professor of pathology at the University of Utah School of Medicine. Dr. Grenache earned his PhD in biomedical sciences from Worcester Polytechnic Institute in Worcester, MA and completed his postdoctoral training in clinical chemistry at Washington University School of Medicine in St. Louis, MO. Dr. Grenache is a fellow in the National Academy of Clinical Biochemistry and is board certified in clinical chemistry by the American Board of Clinical Chemistry. His research interests include reproductive biochemistry and emerging biomarkers of disease.

Objectives

After this presentation, participants will be able to:

Describe the biochemistry and function of hCG.

Explain the limitations of qualitative point-of-care hCG tests and causes of erroneous results.

Evaluate the effect that qualitative point-of-care hCG tests have on turnaround time and patient length of stay.

Sponsored by:

University of Utah School of Medicine, Department of Pathology, and ARUP Laboratories

Please feel free to contactthe Webmaster regarding any questions or comments on this page.

╳

How do I obtain continuing education credit?

To obtain credit, the video lecture must be watched in its entirety, and the quiz must be passed with 80% or higher. You DO NOT have to choose the credit type or enter any user information UNTIL AFTER you have successfully passed the quiz, and only if you want to obtain credit for the video lecture.

Here’s how it works: At the conclusion of the video presentation, a dialogue box will appear prompting you to proceed to the quiz. Once the quiz has been passed, you can choose your desired credit type, and enter the information necessary for the credit to be valid and produce a completion certificate.

After submitting the user information form, a certificate will be generated based on the credit type you have chosen. Following the prompts will allow you to download the certificate which you should keep for your records. Additionally, the information that you entered into the form will be saved in our submission database to verify with the accrediting body that you have completed the continuing education activity. (Your information is only used for proof of completion and to notify you of additional educational opportunities.)

This educational content is being provided FREE OF CHARGE as a service to laboratory medical professionals as part of the academic mission of the University of Utah’s Department of Pathology and ARUP Laboratories.

Please feel free to contact the Webmaster regarding any additional questions or comments.